Dr. Karen E. Knudsen is Chief Executive Officer of the Parker Institute for Cancer Immunotherapy, composed of 14 national PICI institutes and 17 PICI-invested or founded portfolio companies focused on cancer therapeutics, spanning discovery, platform development, and clinical translation. She previously served as Chief Executive Officer of the American Cancer Society and the American Cancer Society Cancer Action Network, and as Executive Vice President of Oncology at Jefferson Health, where she was also Executive Director of the Sidney Kimmel Cancer Center, an NCI-designated comprehensive cancer center. Dr. Knudsen currently serves on the boards of AstraZeneca, 3T Biosciences, Paradigm Health, and NetworkBio, and is a board advisor to Color Health, Transcarent and ArteraAI, with a focus on translational strategy, governance, and commercialization.  Her work has been recognized by Forbes, CNBC, and numerous scientific and medical associations. She is an active member of the CNBC CEO Council and Milken Institute Executive Circle.